Legal Representation
Attorney
Gregory Turocy
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 21, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 25, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 25, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 3, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 19, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 30, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 29, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 29, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 29, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 5, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 26, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 8, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic preparations and substances for medical purposes; Biological reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis, namely medical; Chemical reagents for medical use; Chemical test reagents, namely medical; Clinical diagnostic reagents for medical purposes; Clinical medical reagents; Diagnostic agents for medical use; Diagnostic agents for pharmaceutical use; Diagnostic biomarker reagents for medical purposes; Diagnostic chemical reagents for medical use; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Diagnostic substances for medical use; Diagnostic testing materials for medical use, namely, medical diagnostic test media for gene sequencing of tumor samples, medical diagnostic test media for gene sequencing of blood samples, and medical diagnostic test media for gene sequencing of tissue samples; Immunoassay reagents for medical use; In vitro diagnostic preparations for medical use; Biological indicators for medical diagnosis; Medical diagnostic reagents and assays for testing of body fluids; Preparations for detecting genetic predispositions for medical purposes; preparations consisting of pre-mixed reactants for medical diagnosis; Reagents for analytical purposes, namely for medical purposes; Reagents for blood grouping, namely for medical purposes; Reagents for in-vitro laboratory use, namely for medical purposes; Reagents for use in analysis, namely for medical purposes; Reagents for use with analyzers, namely for medical purposes; Reagents for use in diagnostic tests, namely for medical purposes
Class 042
Analysis of human tissues for medical research; Research laboratory services in the field of cancer diagnostics; Scientific research for medical purposes in the area of cancerous diseases; Medical research laboratory services; Scientific investigations for medical purposes; Providing scientific information in the field of medical disorders and their treatment
Class 044
Advisory services relating to medical problems; Advisory services relating to medical services; Medical analysis of human serum for medical treatment purposes provided by medical laboratories; Medical analysis of human tissues for medical treatment purposes provided by medical laboratories; Breast cancer screening services; Bowel cancer screening services; Cervical cancer screening services; Collection and preservation of human blood; Compilation of medical reports, namely, providing medical information to patients in the form of reports in the field of molecular tumor analysis; Conducting of medical examinations; Health clinic services, namely medical; Genetic testing for medical purposes; DNA screening for medical purposes; Immunodetection services for medical purposes; Lung cancer screening services; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Medical care and analysis services relating to patient treatment; Medical counseling; Medical diagnostic services; Medical screening; Medical services in the field of oncology; Medical services for the treatment of skin cancer; Medical services for the diagnosis of conditions of the human body; Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; Medical laboratory services for the analysis of blood samples taken from patients for diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Providing cancer screening services; Prostate cancer screening services; Preparation of reports providing medical information to patients relating to medical matters in the field of cancer diagnosis; Public health counseling; Provision of medical services; RNA or DNA analysis for cancer diagnosis and prognosis; Services for the testing of blood for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of sera for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of urine for diagnostic and treatment purposes provided by medical laboratories; Testicular cancer screening services; Next generation sequencing of tumor and control samples for diagnostic and treatment purposes provided by medical laboratories; Bioinformatic analysis of next generation sequencing data for pan-cancer diagnostics, provided by medical laboratories
Classification
International Classes
005
042
044